These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
876 related items for PubMed ID: 8057151
21. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU. Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438 [Abstract] [Full Text] [Related]
22. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G. Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190 [Abstract] [Full Text] [Related]
23. Molecular analysis of genomic abnormalities in human gliomas. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestaña A, Rey JA. Cancer Genet Cytogenet; 1994 Apr 01; 73(2):122-9. PubMed ID: 8174086 [Abstract] [Full Text] [Related]
24. Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Ohgaki H, Schäuble B, zur Hausen A, von Ammon K, Kleihues P. Virchows Arch; 1995 Apr 01; 427(2):113-8. PubMed ID: 7582239 [Abstract] [Full Text] [Related]
25. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H. Am J Pathol; 1999 Aug 01; 155(2):387-94. PubMed ID: 10433932 [Abstract] [Full Text] [Related]
26. Somatic mutations of PTEN in glioblastoma multiforme. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Cancer Res; 1997 Oct 01; 57(19):4183-6. PubMed ID: 9331071 [Abstract] [Full Text] [Related]
27. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas. Wu JK, Darras BT. Neurol Res; 1992 Mar 01; 14(1):39-44. PubMed ID: 1351257 [Abstract] [Full Text] [Related]
28. Genetic analyses for predictors of radiation response in glioblastoma. Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT. Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):704-10. PubMed ID: 15978739 [Abstract] [Full Text] [Related]
29. Subsets of glioblastoma multiforme defined by molecular genetic analysis. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Brain Pathol; 1993 Jan 01; 3(1):19-26. PubMed ID: 8269081 [Abstract] [Full Text] [Related]
30. Genetic alterations in pediatric high-grade astrocytomas. Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS. Hum Pathol; 1999 Nov 01; 30(11):1284-90. PubMed ID: 10571506 [Abstract] [Full Text] [Related]
31. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Ohgaki H, Kleihues P. J Neuropathol Exp Neurol; 2005 Jun 01; 64(6):479-89. PubMed ID: 15977639 [Abstract] [Full Text] [Related]
32. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India. Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC, Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C. Cancer Genet Cytogenet; 2010 Apr 15; 198(2):126-34. PubMed ID: 20362227 [Abstract] [Full Text] [Related]
33. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas. Arslantas A, Artan S, Oner U, Müslümanoglu MH, Ozdemir M, Durmaz R, Arslantas D, Vural M, Cosan E, Atasoy MA. Pathol Oncol Res; 2007 Apr 15; 13(1):39-46. PubMed ID: 17387387 [Abstract] [Full Text] [Related]
34. Functional evaluation of p53 and PTEN gene mutations in gliomas. Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han SY, Suzuki T, Shibata H, Kanamaru R, Ishioka C. Clin Cancer Res; 2000 Oct 15; 6(10):3937-43. PubMed ID: 11051241 [Abstract] [Full Text] [Related]
35. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W. Oncol Rep; 2004 Jan 15; 11(1):207-11. PubMed ID: 14654927 [Abstract] [Full Text] [Related]
36. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences. Saxena A, Shriml LM, Dean M, Ali IU. Oncogene; 1999 Feb 11; 18(6):1385-90. PubMed ID: 10022821 [Abstract] [Full Text] [Related]
37. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG. Cancer Res; 1994 Mar 15; 54(6):1397-401. PubMed ID: 8137236 [Abstract] [Full Text] [Related]
38. Amplification of the anonymous marker D17S67 in malignant astrocytomas. Bijlsma EK, Leenstra S, Westerveld A, Bosch DA, Hulsebos TJ. Genes Chromosomes Cancer; 1994 Feb 15; 9(2):148-52. PubMed ID: 7513547 [Abstract] [Full Text] [Related]
40. Instability of microsatellites in human gliomas. Dams E, Van de Kelft EJ, Martin JJ, Verlooy J, Willems PJ. Cancer Res; 1995 Apr 01; 55(7):1547-9. PubMed ID: 7882363 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]